Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Modern Applications in Pharmacy & Pharmacology

Long Haul COVID 19 is the Result of B Lymphocyte Anergy Reversal

Submission: January 05, 2023;Published: January 12, 2023

DOI: 10.31031/MAPP.2023.03.000554

ISSN 2637-7756
Volume3 Issue1

Abstract

SARS-CoV-2 elevates angiotensin 2 which then activates Angiotensin 2 Type 1 Receptor (AT1R) in anergic B cells which reverses anergy (immune tolerance), thereby producing autoimmunity.

Keywords: COVID 19; Autoimmune; SARS-CoV-2; Long-haul; Intervention

-->
Get access to the full text of this article